Trade Rockwell Medical, Inc. - RMTI CFD
Add to favourite- Summary
- Historical Data
Spread | 0.06 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 1.43 |
Open | 1.43 |
1-Year Change | -35% |
Day's Range | 1.43 - 1.51 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 24, 2024 | 1.43 | -0.04 | -2.72% | 1.47 | 1.49 | 1.42 |
Apr 23, 2024 | 1.50 | 0.03 | 2.04% | 1.47 | 1.52 | 1.47 |
Apr 22, 2024 | 1.48 | 0.05 | 3.50% | 1.43 | 1.51 | 1.42 |
Apr 19, 2024 | 1.43 | -0.03 | -2.05% | 1.46 | 1.48 | 1.43 |
Apr 18, 2024 | 1.46 | 0.01 | 0.69% | 1.45 | 1.53 | 1.42 |
Apr 17, 2024 | 1.45 | 0.02 | 1.40% | 1.43 | 1.50 | 1.42 |
Apr 16, 2024 | 1.46 | -0.07 | -4.58% | 1.53 | 1.56 | 1.43 |
Apr 15, 2024 | 1.49 | -0.04 | -2.61% | 1.53 | 1.55 | 1.49 |
Apr 12, 2024 | 1.56 | 0.01 | 0.65% | 1.55 | 1.60 | 1.54 |
Apr 11, 2024 | 1.58 | 0.03 | 1.94% | 1.55 | 1.60 | 1.55 |
Apr 10, 2024 | 1.55 | 0.02 | 1.31% | 1.53 | 1.60 | 1.53 |
Apr 9, 2024 | 1.59 | 0.00 | 0.00% | 1.59 | 1.64 | 1.55 |
Apr 8, 2024 | 1.60 | 0.01 | 0.63% | 1.59 | 1.63 | 1.57 |
Apr 5, 2024 | 1.63 | -0.04 | -2.40% | 1.67 | 1.68 | 1.61 |
Apr 4, 2024 | 1.65 | 0.03 | 1.85% | 1.62 | 1.72 | 1.61 |
Apr 3, 2024 | 1.61 | 0.01 | 0.63% | 1.60 | 1.61 | 1.57 |
Apr 2, 2024 | 1.62 | -0.06 | -3.57% | 1.68 | 1.68 | 1.61 |
Apr 1, 2024 | 1.65 | 0.05 | 3.12% | 1.60 | 1.77 | 1.60 |
Mar 28, 2024 | 1.63 | 0.04 | 2.52% | 1.59 | 1.65 | 1.58 |
Mar 27, 2024 | 1.60 | 0.02 | 1.27% | 1.58 | 1.64 | 1.56 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Rockwell Medical, Inc. Company profile
About Rockwell Medical Inc
Rockwell Medical, Inc. is a commercial-stage, biopharmaceutical company. The Company is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. It is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The Company has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Rockwell Medical Inc revenues decreased 1% to $46.6M. Net loss increased 7% to $23.7M. Revenues reflect United States segment decrease of 1% to $41.9M. Higher net loss reflects Research and Product Development increase of 5% to $5.4M (expense), Interest Income decrease of 92% to $18K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.32 to -$0.25.
Equity composition
Common Stock no Par, 04/11, N/A auth., 17,843,608 issd. Insiders control 14.55%. IPO:1/98,1.8M Common @ $4 + 2.7M Warrants @ $.10 by Mason Hill & Co., Inc. *NOTE: FY'96 = 2 months due to 10/25/96 inception. All financials prior to 2/19/97 are Predecessor.
Industry: | Bio Therapeutic Drugs |
30142 Wixom Road
48393
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com